STOCKHOLM, March 1, 2024 /PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT) and (Nasdaq Stockholm: CALTX) ("Calliditas"), a commercial biopharma company focused on rare diseases today announced that Renee Aguiar-Lucander, CEO of Calliditas will participate in the following March 2024 conferences.  Carnegie Healthcare Seminar, Wednesday, March 6, 2024.  Fireside chat will be held at 10:20 - 10:50 am CET and one-on-one meetings will be available. Jefferies Biotech on the Bay Summit, Wednesday, March 13 ...